The changes are intended to reduce administrative burdens that block Medicare beneficiaries’ timely access to innovative products and to create a more predictable path for Medicare payment, CMS Administrator Seema Verma said in an announcement.
Three specific actions CMS is proposing to streamline and accelerate Medicare coverage, payment and coding for new technologies:
1. Cover external infusion pumps as DME under Medicare Part B in cases where assistance from a skilled home infusion therapy supplier is necessary for safe infusion in the home.
2. Classify all continuous glucose monitors — not just limited to therapeutic ones — as DME, establishing payment amounts for these items as well as related supplies and accessories.
3. Pay more for durable medical equipment, prosthetics, orthotic devices and supplies from suppliers in rural and non-contiguous areas.
Click here for more information on the proposed rule.
More articles on devices:
Centinel Spine patient access program to boost reimbursement support for Prodisc L
OrthoNY opens flagship location — 5 facts
Titan Medical hits $10M technical milestone under Medtronic agreement
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.